No headlines found.
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Globe Newswire (Tue, 8-Sep 8:00 AM ET)
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Globe Newswire (Thu, 13-Aug 4:05 PM ET)
Globe Newswire (Mon, 27-Jul 8:00 AM ET)
Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock trades on the NASDAQ stock market under the symbol FBIOP.
As of October 13, 2026, FBIOP stock price declined to $17.20 with 3,894 million shares trading.
FBIOP has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, FBIOP traded as high as $21.43 and as low as $4.72.
FBIOP has outperformed the market in the last year with a price return of +141.1% while the SPY ETF gained +20.3%. However, in the short term, FBIOP had mixed performance relative to the market. It has underperformed in the last 3 months, returning -7.3% vs +3.3% return in SPY. But in the last 2 weeks, FBIOP shares have fared better than the market returning +4.1% compared to SPY +1.6%.
FBIOP support price is $17.11 and resistance is $18.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FBIOP shares will trade within this expected range on the day.
